IRIDEX CORP Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
IRIDEX CORP (IRIX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $1.21 per share for the 6-month period ending 2026-07-04, per its 10-Q filed 2026-08-18.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-18
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-04-04 was $1.23, a 33.70% increase year-over-year.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-29 was $0.92, a 66.91% decline year-over-year.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-30 was $2.78, a 21.93% increase year-over-year.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-04-01 was $2.28, a 51.80% decline year-over-year.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2026 was $0.96, a 59.49% decline from fiscal 2024.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $2.37, a 11.27% increase from fiscal 2023.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $2.13, a 15.81% decline from fiscal 2022.
- IRIDEX CORP share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $2.53, a 61.95% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-07-04 | $1.21 10-Q · filed 2026-08-18 | |||
| 2026-04-04 | $1.23 10-Q · filed 2026-05-19 | |||
| 2026-01-03 | $0.96 10-K · filed 2026-04-02 | |||
| 2025-09-27 | $0.96 10-Q · filed 2025-11-12 | |||
| 2025-06-28 | $0.94 10-Q · filed 2025-08-12 | |||
| 2025-03-29 | $0.92 10-Q · filed 2025-05-13 | |||
| 2024-12-28 | $2.37 10-K · filed 2026-04-02 | |||
| 2024-09-28 | $2.67 10-Q · filed 2024-11-12 | |||
| 2024-06-29 | $2.94 10-Q · filed 2024-08-08 | |||
| 2024-03-30 | $2.78 10-Q · filed 2024-05-14 | |||
| 2023-12-30 | $2.13 10-K · filed 2025-03-27 | |||
| 2023-09-30 | $2.13 10-Q · filed 2023-11-20 | |||
| 2023-07-01 | $2.22 10-Q · filed 2023-08-10 | |||
| 2023-04-01 | $2.28 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $2.53 10-K · filed 2024-03-29 | |||
| 2022-10-01 | $3.59 10-Q · filed 2022-11-10 | |||
| 2022-07-02 | $4.44 10-Q · filed 2022-08-15 | |||
| 2022-04-02 | $4.73 10-Q · filed 2022-05-12 | |||
| 2022-01-01 | $6.65 10-K · filed 2023-03-09 | |||
| 2021-10-02 | $6.62 10-Q · filed 2021-11-12 | |||
| 2021-07-03 | $6.83 10-Q · filed 2021-08-12 | |||
| 2021-04-03 | $4.90 10-Q · filed 2021-05-12 | |||
| 2021-01-02 | $2.13 10-K · filed 2022-03-15 | |||
| 2020-09-26 | $2.13 10-Q · filed 2020-11-10 | |||
| 2020-06-27 | $2.15 10-Q · filed 2020-08-07 | |||
| 2020-03-28 | $2.27 10-Q · filed 2020-05-12 | |||
| 2019-12-28 | $4.55 10-K · filed 2021-03-23 | |||
| 2019-09-28 | $4.86 10-Q · filed 2019-11-08 | |||
| 2019-06-29 | $4.90 10-Q · filed 2019-08-07 | |||
| 2019-03-30 | $4.33 10-Q · filed 2019-05-07 | |||
| 2018-12-29 | $6.00 10-K · filed 2020-03-13 | |||
| 2018-09-29 | $6.22 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | $6.10 10-Q · filed 2018-08-08 | |||
| 2018-03-31 | $5.88 10-Q · filed 2018-05-08 | |||
| 2017-12-30 | $9.90 10-K · filed 2019-03-29 | |||
| 2017-09-30 | $10.05 10-Q · filed 2017-11-07 | |||
| 2017-07-01 | $13.15 10-Q · filed 2017-08-08 | |||
| 2017-04-01 | $14.61 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | $13.71 10-K · filed 2018-03-14 | |||
| 2016-10-01 | $13.30 10-Q · filed 2016-11-07 | |||
| 2016-07-02 | $10.60 10-Q · filed 2016-08-08 | |||
| 2016-04-02 | $10.33 10-Q · filed 2016-05-09 | |||
| 2016-01-02 | $9.38 10-K · filed 2018-03-14 | |||
| 2015-10-03 | $9.92 10-Q · filed 2015-11-10 | |||
| 2015-07-04 | $10.62 10-Q · filed 2015-08-10 | |||
| 2015-04-04 | $10.73 10-Q · filed 2015-05-12 | |||
| 2015-01-03 | $8.61 10-K · filed 2017-03-15 | |||
| 2014-09-27 | $8.66 10-Q · filed 2014-11-03 | |||
| 2014-06-28 | $8.72 10-Q · filed 2014-08-04 | |||
| 2014-03-29 | $8.66 10-Q · filed 2014-05-05 | |||
| 2013-12-28 | $5.69 10-K · filed 2016-03-31 | |||
| 2013-09-28 | $5.59 10-Q · filed 2013-11-04 | |||
| 2013-06-29 | $4.74 10-Q · filed 2013-08-05 | |||
| 2013-03-30 | $4.74 10-Q · filed 2013-05-06 | |||
| 2012-12-29 | $3.92 10-K · filed 2015-04-02 | |||
| 2012-09-29 | $4.00 10-Q · filed 2012-11-05 | |||
| 2012-06-30 | $4.10 10-Q · filed 2012-08-07 | |||
| 2011-12-31 | $3.59 10-K · filed 2014-03-27 | |||
| 2011-01-01 | $3.98 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |